Table 3.

Proposed Thromboprophylaxis Protocols During COVID-19 Infection.

	Standard dose prophylaxis Hospitalization in the medical ward
glomerular filtration rate* (ml/mn)	Weight 50-99 kg	Weight ≥100 kg
≥30	Enoxaparin 40 mg/d Nadroparin 2 850 UI/d Tinzaparin 4500 UI/d Fondaparinux 2.5 mg/d	Enoxaparin 60 mg/d Nadroparin 5700 UI/d Fondaparinux 5 mg/d
20-30	Enoxaparin 20 mg/d Tinzaparin 3500 UI/d	UFH 5000 UI x 3 /d Targeted anti-factor Xa level: 0.50-0.70 IU/mL
<20	UFH 5000 UI x 2 /d Targeted anti-factor Xa level: 0.30-0.50 IU/mL
	Hospitalization in ICU Enhanced dose prophylaxis
≥30	Enoxaparin 40 mg x 2/d Nadroparin 2850 x 2/d	Enoxaparin 60 mg x 2/d Nadroparin 5700 UI x 2/d
<30	UFH 5000 UI x 3 /d or 15.000 UI / 24 h continuous IV	UFH10 000 UI x 2 /d or 20.000 UI / 24 h continuous IV

UFH: unfractioned heparin; UI: international units; IV: intra-venous; d: day; ICU: intensive care unit; kg: kilogram; * Cockroft.